GFACX
Price
$63.16
Change
-$1.29 (-2.00%)
Updated
Mar 3 closing price
Net Assets
298.54B
KLGIX
Price
$49.66
Change
-$1.18 (-2.32%)
Updated
Mar 3 closing price
Net Assets
909.07M
Ad is loading...

GFACX vs KLGIX

Header iconGFACX vs KLGIX Comparison
Open Charts GFACX vs KLGIXBanner chart's image
American Funds Growth Fund of Amer C
Price$63.16
Change-$1.29 (-2.00%)
VolumeN/A
Net Assets298.54B
NYLI WMC Growth
Price$49.66
Change-$1.18 (-2.32%)
VolumeN/A
Net Assets909.07M
GFACX vs KLGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. KLGIX commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and KLGIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 299B vs. KLGIX (909M). GFACX (0.00) and KLGIX (0.00) have matching dividends . GFACX was incepted earlier than KLGIX: GFACX (24 years) vs KLGIX (15 years). KLGIX is a more actively managed with annual turnover of: 42.00 vs. GFACX (31.00). GFACX has a lower initial minimum investment than KLGIX: GFACX (250) vs KLGIX (1000000). KLGIX annual gain was more profitable for investors over the last year : 5.55 vs. GFACX (3.95). GFACX return over 5 years is better than : 35.30 vs. KLGIX (32.92).
GFACXKLGIXGFACX / KLGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years15 years-
Gain YTD-0.941-2.87533%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets299B909M32,893%
Annual Yield % from dividends0.000.00-
Returns for 1 year3.955.5571%
Returns for 3 years14.8231.7947%
Returns for 5 years35.3032.92107%
Returns for 10 years51.1054.9293%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CERT11.94-0.04
-0.33%
Certara
CHWY35.90-1.36
-3.65%
Chewy
SMWB9.11-0.43
-4.51%
Similarweb Ltd
NVCT6.20-0.49
-7.32%
Nuvectis Pharma
LIDR0.58-0.05
-8.57%
AEye